A detailed history of Rise Advisors, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Rise Advisors, LLC holds 453 shares of BAX stock, worth $13,363. This represents 0.01% of its overall portfolio holdings.

Number of Shares
453
Previous 450 0.67%
Holding current value
$13,363
Previous $15,000 13.33%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$32.85 - $40.26 $98 - $120
3 Added 0.67%
453 $17,000
Q2 2024

Jul 09, 2024

SELL
$32.87 - $43.55 $558 - $740
-17 Reduced 3.64%
450 $15,000
Q1 2024

Apr 09, 2024

BUY
$37.88 - $43.77 $17,689 - $20,440
467 New
467 $19,000
Q3 2023

Oct 10, 2023

SELL
$37.32 - $49.29 $223 - $295
-6 Closed
0 $0
Q2 2022

Jul 28, 2022

BUY
$63.83 - $80.0 $382 - $480
6 New
6 $0

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.